Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Major breakthrough in the diagnosis of parasitic diseases

28.04.2010
Chagas disease is one of the most deadly parasitic diseases in the world. It affects more than 10 million people, primarily in the Americas. In South America alone it kills 50 000 people each year. A reliable and rapid diagnosis is the key in the battle against infection but until now, this has been next to impossible. Dr. Momar Ndao and his team at the Research Institute of the MUHC have developed a new diagnostic approach that will help in the fight against Chagas disease.Their results were recently published in the Journal of Clinical Microbiology.

Endemic in South America, the American trypanosomiasis, or Chagas disease, is transmitted to humans via the parasite Trypanosoma cruzi. The disease is usually transmitted through the bite of an infected insect or ‘kissing bug’. The symptoms are variable, but as the disease progresses serious chronic symptoms can appear, such as heart disease and malformation of the intestines. Most people affected may remain without symptoms for years, making diagnosis difficult.

Chagas disease is also transmitted from mother to unborn child and can be passed on for as many as four generations without symptoms. "In other words, a person born in North America by a mother who was infected can transmit the disease to offspring without having traveled," says Dr. Ndao, Laboratory Director of the National Reference Center for Parasitology (NRCP) of the Research Institute. There is an urgent need for action on this disease as it is under-diagnosed and there is no effective treatment.

This situation raises some serious public health concerns with respect to blood transfusions and organ transplants, because many people may be silent carriers of the disease. "The aim of our study was to find new approaches to improve reliability of diagnosis and screening of blood banks," says Dr. Ndao, who is also a researcher at the Centre for Host Parasite Interactions at McGill University.

The researchers have validated a reliable screening technique using mass spectrometry technology that identifies common biological markers - or biomarkers - between the interaction of host (humans) and the parasite. They found that in 99% of cases, the parasites left very specific markers. 'It's as if the parasite left his own signature in the infected person, which could help to diagnose Chagas disease” says Dr. Ndao.

"The use of these biomarkers is a revolution in diagnostic confidence and protection of possible contamination of blood banks,” says Dr. Ndao “Moreover, these biomarkers have potential therapeutic effects of paving the way for the development of vaccines for Chagas, which could be extended to other parasitic diseases.”

Funding
This study was made possible by grants from the Canadian Institutes of Health Research (CIHR) and by McGill University.

About the Study

The article “Identification of Novel Diagnostic Serum Biomarkers for Chagas’ Disease in Asymptomatic Subjects by Mass Spectrometric Profiling,” published in The Journal of Clinical Microbiology, was co-authored by Momar Ndao and Brian J. Ward from the RI of the MUHC and McGill University; Terry W. Spithill from McGill University and Charles Stuart University and Cynthia Santamaria from McGill University; Rebecca Caffrey from University of California, Berkeley; Hongshan Li from High School of Business, California; Vladimir N. Podust from Vermillion Inc., California, Regis Perichon from Diagnostic Biomarker Evaluation Group Ortho-Clinical Diagnostics, New Jersey; Alberto Ache from Ministerio de Salud y Desarrollo Social, Caracas, Venezuela; Mark Duncan, University of Colorado and Malcolm R. Powell from Western Carolina University and Universidad del Valle Guatemala.

Julie Robert | EurekAlert!
Further information:
http://www.muhc.mcgill.ca

Further reports about: Biomarker Chagas Chagas disease MUHC biological marker microbiology

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>